SI-BONE Inc. (SIBN)

Business: SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

IPO Date: 17-Oct-2018

CEO & Director: Ms. Laura A. Francis MBA

Chief Financial Officer: Mr. Anshul Maheshwari

Listing: NASDAQ: SIBN

Country: United States

Headquarters: Santa Clara, CA

Website: https://si-bone.com

Market cap: $461.22 Mln

Revenue (TTM): $92.15 Mln

Earnings (TTM): $-61.74 Mln

Cash: $130.73 Mln

Total Debt: $40.20 Mln

Insider's Holding: 1.69%

Liquidity: Low

52 Week range: $11.89 - 32.13

Shares outstanding: 33,913,000

8 Years Aggregate:

• CFO: $-203.67 Mln
• EBITDA: $-162.24 Mln
• Net Profit: $-255.71 Mln